Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Vaccine

• Publication date

  2010-09-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2010.06.118PMID 20637762
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation

  2010cited by this paper
• Bordetella pertussis Strains with Increased Toxin Production Associated with Pertussis Resurgence

  2009cited by this paper
• Antibody decay after immunisation of health-care workers with an acellular pertussis vaccine

  2009cited by this paper
• XBP1 governs late events in plasma cell differentiation and is not required for antigen-specific memory B cell development

  2009cited by this paper
• Long-term presence of memory B-cells specific for different vaccine components.

  2009cited by this paper
• Multiple layers of B cell memory with different effector functions

  2009cited by this paper
• Requirement of B Cells for Generating CD4+ T Cell Memory1

  2009cited by this paper
• Improving pertussis vaccination

  2009cited by this paper
• B-cell responses to vaccination at the extremes of age

  2009cited by this paper
• First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin.

  2009cited by this paper
• Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti‐Fim2/3 antibodies after vaccination and infection

  2009cited by this paper
• Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus.

  2008cited by this paper
• Immunodominance in Mouse and Human CD4+ T-Cell Responses Specific for the Bordetella pertussis Virulence Factor P.69 Pertactin

  2008cited by this paper
• Improving the cellular pertussis vaccine: increased potency and consistency.

  2008cited by this paper
• The Magnitude of the Antibody and Memory B Cell Responses during Priming with a Protein-Polysaccharide Conjugate Vaccine in Human Infants Is Associated with the Persistence of Antibody and the Intensity of Booster Response1

  2008cited by this paper
• Maintenance of the plasma cell pool is independent of memory B cells

  2008cited by this paper
• Maintenance of serological memory

  2008cited by this paper
• Hyperproliferation of B Cells Specific for a Weakly Immunogenic PorA in a Meningococcal Vaccine Model

  2008cited by this paper
• Factors contributing to pertussis resurgence.

  2008cited by this paper
• Cutting Edge: The Dependence of Plasma Cells and Independence of Memory B Cells on BAFF and APRIL1

  2008cited by this paper
• Duration of humoral immunity to common viral and vaccine antigens.

  2007cited by this paper
• Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life.

  2007cited by this paper
• Immunomodulation in the pathogenesis of Bordetella pertussis infection and disease.

  2007cited by this paper
• Optimal Long-Term Humoral Responses to Replication-Defective Herpes Simplex Virus Require CD21/CD35 Complement Receptor Expression on Stromal Cells

  2006cited by this paper
• Primary T Cell Expansion and Differentiation In Vivo Requires Antigen Presentation by B Cells1

  2006cited by this paper
• Intrinsic properties of human and murine memory B cells

  2006cited by this paper
• Competence and competition: the challenge of becoming a long-lived plasma cell

  2006cited by this paper
• Differentiation of memory B and T cells.

  2006cited by this paper
• Bordetella pertussis-Infected Human Monocyte-Derived Dendritic Cells Undergo Maturation and Induce Th1 Polarization and Interleukin-23 Expression

  2005cited by this paper
• Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1/2-6 1/2 years after the third vaccine dose.

  2005cited by this paper
• Antigen-specific memory B cell development.

  2005cited by this paper
• Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens.

  2005cited by this paper
• Duration of Immunity Against Pertussis After Natural Infection or Vaccination

  2005cited by this paper
• Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study.

  2004cited by this paper
• Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system.

  2004cited by this paper
• Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine.

  2004cited by this paper
• Molecules of infectious agents as immunomodulatory drugs.

  2004cited by this paper
• Regulation of B Cell Differentiation and Plasma Cell Generation by IL-21, a Novel Inducer of Blimp-1 and Bcl-61

  2004cited by this paper
• Haemophilus influenzae Type b-Outer Membrane Protein Complex Glycoconjugate Vaccine Induces Cytokine Production by Engaging Human Toll-Like Receptor 2 (TLR2) and Requires the Presence of TLR2 for Optimal Immunogenicity1

  2004cited by this paper
• Pertussis in Poland.

  2004cited by this paper
• Immunological memory in humans.

  2004cited by this paper
• Duration of antiviral immunity after smallpox vaccination

  2003cited by this paper
• Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination 1

  2003cited by this paper
• Immunogenicity of, and Immunologic Memory to, a Reduced Primary Schedule of Meningococcal C-Tetanus Toxoid Conjugate Vaccine in Infants in the United Kingdom

  2003cited by this paper
• Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells

  2002cited by this paper
• Immunity to Bordetella pertussis.

  2001cited by this paper
• Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes.

  2001cited by this paper
• International collaborative study: evaluation of proposed International Reference Reagent of pertussis antiserum (mouse) 97/642.

  2001cited by this paper
• Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children.

  2000cited by this paper
• Protective Immunity to Bordetella pertussis Requires Both B Cells and Cd4+ T Cells for Key Functions Other than Specific Antibody Production

  2000cited by this paper
• Cell-Mediated Immune Responses in Four-Year-Old Children after Primary Immunization with Acellular Pertussis Vaccines

  1999cited by this paper
• Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996.

  1999cited by this paper
• Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working Group.

  1998cited by this paper
• A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.

  1998cited by this paper
• Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.

  1998cited by this paper
• Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis.

  1998cited by this paper
• Humoral immunity due to long-lived plasma cells.

  1998cited by this paper
• The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model.

  1998cited by this paper
• Immunity to tetanus, diphtheria and poliomyelitis in the adult population of Sweden in 1991.

  1998cited by this paper
• Pertussis notifications in Australia, 1991 to 1997.

  1997cited by this paper
• The changing preference of T and B cells for partners as T‐dependent antibody responses develop

  1997cited by this paper
• Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance.

  1997cited by this paper
• Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine.

  1997cited by this paper
• Quantification of cell-associated and free antigens in Bordetella pertussis suspensions by antigen binding ELISA.

  1997cited by this paper
• Immunological Memory and Protective Immunity: Understanding Their Relation

  1996cited by this paper
• Human cytotoxic T-cell memory: long-lived responses to vaccinia virus

  1996cited by this paper
• Pertussis in Quebec: ongoing epidemic since the late 1980s.

  1995cited by this paper
• Return of epidemic pertussis in the United States.

  1994cited by this paper
• Quantification of pertussis toxin, filamentous haemagglutinin, 69 kDa outer membrane protein, agglutinogens 2 and 3 and lipopolysaccharide in the Danish whole-cell pertussis vaccine.

  1993cited by this paper
• Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines.

  1992cited by this paper
• The persistence of neutralizing antibodies after revaccination against smallpox.

  1990cited by this paper
• Serospecific protection of mice against intranasal infection with Bordetella pertussis.

  1989cited by this paper
• Recent primary toxoplasma infection indicated by a low avidity of specific IgG.

  1989cited by this paper
• Separation and purification of the hemagglutinins from Bordetella pertussis

  1983cited by this paper
• Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase.

  1983cited by this paper

• Antibody and B-cell immune responses against Bordetella pertussis following infection and immunization.

  2023cites this paper
• The whole-cell pertussis vaccine imposes a broad effector B cell response in mouse heterologous prime-boost settings

  2022cites this paper
• Vaccine-Induced Cellular Immunity against Bordetella pertussis: Harnessing Lessons from Animal and Human Studies to Improve Design and Testing of Novel Pertussis Vaccines

  2021cites this paper
• Naive B Cells with High‐Avidity Germline‐Encoded Antigen Receptors Produce Persistent IgM+ and Transient IgG+ Memory B Cells

  2018cites this paper
• What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines.

  2017cites this paper
• Adaptive immune response to whole cell pertussis vaccine reflects vaccine quality: A possible complementation to the Pertussis Serological Potency test.

  2016cites this paper
• Biochemical characterization of monoclonal antibodies to the Bordetella pertussis Filamentous hemagglutinin (FHA) and Pertussis toxin (PTx) : implications for improved acellular pertussis vaccine design

  2015cites this paper
• Unconventional, adenosine‐producing suppressor T cells induced by dendritic cells exposed to BPZE1 pertussis vaccine

  2015cites this paper
• Roads to the development of improved pertussis vaccines paved by immunology

  2015cites this paper
• Bordetella filamentous hemagglutinin and fimbriae: critical adhesins with unrealized vaccine potential.

  2015cites this paper
• Pertussis vaccines and the challenge of inducing durable immunity.

  2015cites this paper
• Vaccination in the Elderly: What Can Be Recommended?

  2014cites this paper
• B-CELL RESPONSES AFTER PERTUSSIS VACCINATION

  2014cites this paper
• Réponses immunitaires du grand prématuré à la vaccination contre la coqueluche

  2013cites this paper
• The Virulence Factors of Bordetella pertussis: Talented Modulators of Host Immune Response

  2013cites this paper
• Resurgence of pertussis calls for re-evaluation of pertussis animal models

  2012cites this paper
• Pulmonary Vaccine Delivery: A Realistic Approach?

  2012cites this paper
• Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.

  2012cites this paper
• Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.

  2011cites this paper
• Reply to the letter by Dr. Stanley Plotkin

  2011cites this paper
• Pertussis vaccines: where to now?

  2011cites this paper